This article reviews all of the materials currently available for soft tissue augmentation as well as those that have recently been available and those undergoing current evaluation for possible use in the future. Techniques, side effects, and tips on the use of each of the substances are described, and the future of soft tissue augmentation is discussed.
BloemJJvan der WaalI: Paraffinoma of the face. Oral Surg38:675, 1974.
3.
BartonJLCunliffWJ: The subcutaneous fat: Oil granuloma. In RookASWilkinsonDSEblingFJChampionRHBurtonJL (eds.) Textbook of Dermatology. Oxford: Blackwell Press, 1986. p. 1870.
4.
Testimony of the FDA Commissioner, Dr. David Kessler, before the House of Representatives Human Resources and Intergovernmental Relations Subcommittee, June 11, 1991, regarding “Promoting Drugs for Unapproved Uses.”
ClarkDPHankeCW: Dermal implants: Safety of products injected for soft-tissue augmentation. J Am Acad Dermatol21: 992, 1989.
7.
FDA Medical Bulletin22:3, April 1992.
8.
SahnEEGarenPD: Scleroderma following augmentation mammoplasty: Report of a case and review of the literature. Arch Dermatol126:1198, 1990.
9.
KaiserWBiesenbachG: Human adjuvant disease: Remission of silicone induced autoimmune disease after explanation of breast augmentation. Ann Rheum Dis49:937, 1990.
10.
FDA approval letter to Collagen Corp., July 22, 1981.
11.
McPhersonJMLedgerPWSawamuraS: The preparation and physicochemical characterization of an injectable form of reconstituted, glutaraldehyde cross-linked, bovine corium collagen. J Biomed Mater Res20:79, 1986.
12.
ElsonML: Clinical assessment of zyplast implant: A year of experience for soft tissue contour correction. J Am Acad Dermatol18:707, 1988.
13.
ElsonML: Correction of dermal contour defects with injectable collagens: Choosing and using these materials. Seminars in Dermatol6:77, 1987.
14.
ElsonML: Clinical use of collagen injectable materials. Cosm Dermatol July/August: 15, 1989.
15.
KleinAW: Indications and implantation techniques for the various formulations of injectable collagen. J Dermatol Surg Oncol14Suppl 1:27, 1988.
16.
ElsonML: Soft tissue augmentation of periorbital fine lines and the orbital groove with Zyderm I and Fine Gauge Needles. J Dermatol Surg Oncol (In press).
17.
ElsonML: Techniques for Lip Augmentation Discussed. Cosm Derm, 16, Nov 1990.
18.
ElsonML: Side-effects of injectable collagen. In Harahap (ed.) Side-effects of Dermatologic Cosmetic Surger. Heidelberg: Springer Verlag, 1992.
19.
CucinRLBarekD: Complications of injectable collagen implants. Plast Reconstr Sur71:731, 1983.
20.
ElsonML: Soft Tissue augmentation. In HankeCW (ed.), Fundamentals of Dermatologic Surgery for the Dermatology Resident (In press).
ElsonL: The role of skin testing in the use of collagen injectable materials. J Dermatol Surg Oncol15: 301, 1989.
23.
HankeCWStegmanSJ: Abscess formation and local necrosis following treatment with Zyderm and Zyplast collagen implant. J Am Acad Dermatol25:319, 1991.
24.
Personal communication. Dr. Dan Jolivette, Collagen Corporation, Palo Alto, California. May, 1992.
25.
20/20 News Program. ABC, New York, NY. February 22, 1991.
26.
DeLustroFDaschJ: Immune response to allogeneic and xenogeneic implants of collagen and collagen derivatives. Clin Orthop260:263, 1990.
27.
ElsonML: Injectable collagen and autoimmune disease. Submitted for publication 1992.
28.
LyonMCBlockDA: Predisposing factors in polymyosistis/dermatomyositis: Results of a nationwide survey. J Rheumatol16:1218, 1989.
29.
MillikanLRosenT: Treatment of depressed cutaneous scars with gelatin matrix implant: A multicenter study. J Am Acad Dermatol16:1155, 1987.
30.
MillikanLBanksK: A 5-year safety and efficacy evaluation with Fibrel in the correction of cutaneous scars following one or two treatments. J Dermat Surg Oncol17:223, 1991.
PinskiKSRoenigkHH: Autologous fat transplantation. Long term follow-up. J Dermatol Surg Oncol18:179, 1992.
34.
ElsonML: Soft tissue augmentation: A review of available materials. Cosm Derm4:10, 1991.
35.
Personal communication, NewmanJulius MD. Philadelphia, PA. May, 1992.
36.
DierickxPDerumeauxL: Comparative study of the clinical efficiency of a 2% collagen solution and a 3.5% collagen dispersion on 60 patients. Paper presented at the Vth International Congress of Dermatologic Surgery, Jerusalem, Israel, Oct. 1984.
37.
MiyataTTairaT: Collagen engineering for biomaterial use. Clin Materials9:139, 1992.
38.
CarruthersJDACarruthersJA. Treatment of glabellar frown lines with C. Botulinum A exotoxin. J Dermatol Surg Oncol18:17, 1992.
39.
PitanguyI: Indications for and treatment of frontal and glabellar wrinkles in an analysis of 3,404 consecutive cases of rhytidectomy. Plast Reconstr Surg67(2):157, 1981.
